Lineage Cell Therapeutics Inc (LCTX) — Net Asset Momentum

Latest YoY growth as of December 2024: +24.2%

Lineage Cell Therapeutics Inc (LCTX) recorded a net asset momentum of 24.2% as of December 2024, with net assets of $77.01 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Lineage Cell Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.

YoY Momentum

+24.2%
Year-over-year

Current Net Assets

$77.01 Million
USD · December 2024

Years of Data

34
1991 – 2024

Country

USA
NYSE MKT

Lineage Cell Therapeutics Inc Net Asset Momentum (1991–2024)

This chart tracks Lineage Cell Therapeutics Inc's year-over-year net asset growth across 34 annual reporting periods from 1991 to 2024. The most recent momentum reading is +24.2%, with net assets of $77.01 Million USD as of December 2024. For live market cap and overall valuation, see how much is Lineage Cell Therapeutics Inc worth.

Annual Net Asset History for Lineage Cell Therapeutics Inc (1991–2024)

The table below shows the complete annual net asset history for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 34 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check LCTX tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Year Net Assets (USD) Total Assets Total Liabilities YoY Momentum
2024 $77.01 Million $113.22 Million $36.21 Million ▲ +24.2%
2023 $62.02 Million $101.02 Million $39.00 Million ▼ -13.8%
2022 $71.94 Million $123.66 Million $51.73 Million ▼ -20.9%
2021 $90.90 Million $174.54 Million $83.65 Million ▼ -4.4%
2020 $95.13 Million $107.95 Million $12.82 Million ▼ -14.5%
2019 $111.25 Million $125.48 Million $14.23 Million ▲ +20.6%
2018 $92.25 Million $101.66 Million $9.41 Million ▼ -43.8%
2017 $164.26 Million $173.24 Million $8.98 Million ▲ +25.9%
2016 $130.51 Million $142.57 Million $12.06 Million ▲ +70.7%
2015 $76.45 Million $94.66 Million $18.21 Million ▲ +21.9%
2014 $62.72 Million $74.90 Million $12.18 Million ▲ +48.4%
2013 $42.26 Million $57.73 Million $15.47 Million ▲ +74.0%
2012 $24.29 Million $29.75 Million $5.45 Million ▼ -41.4%
2011 $41.46 Million $45.83 Million $4.37 Million ▼ -16.1%
2010 $49.43 Million $53.27 Million $3.85 Million ▲ +347.4%
2009 $11.05 Million $13.43 Million $2.39 Million ▲ +354.1%
2008 $-4.35 Million $1.04 Million $5.38 Million ▼ -42.7%
2007 $-3.05 Million $175.10K $3.22 Million ▼ -63.3%
2006 $-1.87 Million $650.51K $2.52 Million ▼ -848.8%
2005 $-196.58K $1.96 Million $2.16 Million ▼ -157.0%
2004 $344.77K $1.52 Million $1.18 Million ▲ +114.2%
2003 $-2.43 Million $1.07 Million $3.50 Million ▼ -107.5%
2002 $-1.17 Million $1.50 Million $2.67 Million ▼ -1081.9%
2001 $-99.09K $1.94 Million $2.04 Million ▼ -107.5%
2000 $1.32 Million $1.68 Million $359.75K ▼ -74.1%
1999 $5.08 Million $5.68 Million $595.51K ▲ +111.8%
1998 $2.40 Million $2.80 Million $400.00K ▼ -63.1%
1997 $6.50 Million $8.30 Million $1.80 Million ▲ +132.1%
1996 $2.80 Million $3.00 Million $200.00K ▲ +0.0%
1995 $2.80 Million $3.00 Million $200.00K ▼ -12.5%
1994 $3.20 Million $3.60 Million $400.00K ▼ -44.8%
1993 $5.80 Million $5.90 Million $100.00K ▲ +70.6%
1992 $3.40 Million $3.50 Million $100.00K ▼ -26.1%
1991 $4.60 Million $4.80 Million $200.00K